What the AI Research tells us vs what people are saying! If you read recent scientific reviews on artificial intelligence (AI) in the pharmaceutical industry, you get a clear message: AI is transforming drug discovery, clinical development, manufacturing, and safety.¹⁻⁵ If you talk to bench scientists, clinical teams, or data scientists over coffee, you often hear a more complicated story: pockets of impressive success, a lot of incremental improvements, and quite a few stall

For generations, treating cancer has relied on a pretty brutal calculus: hit the body hard and hope the cancer dies first. Traditional chemotherapy is essentially a scorched-earth strategy. It works, but at a massive cost—wrecking the heart, gut, and nervous system along with the tumour. . For decades, researchers have chased a deceptively simple question: What if we could send the drug only where it’s actually needed? Antibody-drug conjugates, or ADCs, are the most promising

Most executive searches in life sciences begin with a familiar brief. Strong scientific background. Commercial acumen. Proven track record. It is a reasonable list. It is also increasingly insufficient. What if the leadership profile you are searching for is based on a role that no longer exists?

Could the Eye Become the Blueprint for Regenerative Medicine?